MedPath

Investigation of vital prognosis of Gliadel(GLI02T)

Not Applicable
Conditions
malignant glioma
Registration Number
JPRN-jRCT1080222548
Lead Sponsor
Eisai Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
250
Inclusion Criteria

malignant glioma, patients enrolled in study GLI01S

Exclusion Criteria

1)to contraindication of Gliadel
2)Not applicable to indications of Gliadel

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath